Adaptimmune Therapeutics plc
ADAP
Health Care
1
exclusion reason
1 theme
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company developing engineered T-cell therapies for cancer. Its core pipeline of SPEAR T‑cell candidates targets solid tumors, including synovial sarcoma, lung cancer, and head and neck cancer. As a pharmaceutical company developing novel biologic therapies, Adaptimmune’s preclinical and clinical research involves animal testing as a standard component of product development and regulatory compliance. The company’s SEC filings and scientific publications document the use of animal models to evaluate the safety, efficacy, and mechanism of its T-cell therapies prior to human trials. This reliance on animal testing is inherent to its business model and regulatory pathway for drug approval.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.